Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Magnetic Resonance Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 27 Breast Neoplasms 26 Brain Neoplasms 19 Neoplasms 14 Glioma 8 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 6 Lymphoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Lung Neoplasms 4 Liver Neoplasms 4 Disease 4 Colonic Neoplasms 4 Central Nervous System Neoplasms 4 Astrocytoma 4 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2 Oligodendroglioma 2

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Cyclophosphamide 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Observation 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Injections 2 Indocyanine Green 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04394052 2020-07-21

TUMOSTEO II

Central Hospital, Nancy, France

Bone Neoplasms, Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡